Metformin, the low-cost diabetic drug that has been also touted as a miracle anti-aging medicine, has yet another feather in its cap.
A study from the University of Minnesota found metformin lowered the COVID-19 death risk between 21% and 24% among women who already took the drug to treat their diabetes and blood sugar levels.
According to Insider, lead study author Dr. Christopher Tignanelli said people should not seek out metformin as a virus cure, but added his research opened up avenues of possibilities for non-vaccine treatments for the coronavirus.
He said metformin's anti-inflammatory properties might lessen the severe immune response that often kills patients with COVID-19.
According to the Star Tribune, Tignanelli's study was based on a UnitedHealthcare database of 73,000 patients with COVID-19, but focused on 6,000 who were obese and had diabetes. Among them, 2,000 patients had taken metformin. It has been shown both obesity and diabetes increase one's risk of complications from the virus, but it appears the inexpensive drug mitigates that risk.
Metformin, which costs a nickel per pill, has been also hailed as a "miracle" anti-aging drug. People who take metformin tend to be healthier and live longer with fewer cardiovascular events. They are also less likely to suffer from dementia and Alzheimer's, according to Wired. Research shows those who take the medication have a much lower risk of getting cancer than people who take other diabetes medications — as much as 25-40% less risk.
© 2022 Newsmax. All rights reserved.